Clinical Trial Update: A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis [Phase 1]

View source ↗

Summary

RESTEN-MP was evaluated in a Phase 1b study for focal de novo stenosis in patients with coronary artery disease. The trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stent Restenosis

Drugs mentioned

• RESTEN-MP

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Coronary Artery Disease, Coronary Stent Restenosis | Phase 1 | Status: TERMINATED